Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
07 07 2023
Historique:
medline: 25 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

Metastasis - the systemic spread of cancer - is the leading cause of cancer-related deaths. Although metastasis is commonly thought of as a unidirectional process wherein cells from the primary tumor disseminate and seed metastases, tumor cells in existing metastases can also redisseminate and give rise to new lesions in tertiary sites in a process known as "metastasis-from-metastases" or "metastasis-to-metastasis seeding." Metastasis-to-metastasis seeding may increase the metastatic burden and decrease the patient's quality of life and survival. Therefore, understanding the processes behind this phenomenon is crucial to refining treatment strategies for patients with metastatic cancer. Little is known about metastasis-to-metastasis seeding, due in part to logistical and technological limitations. Studies on metastasis-to-metastasis seeding rely primarily on sequencing methods, which may not be practical for researchers studying the exact timing of metastasis-to-metastasis seeding events or what promotes or prevents them. This highlights the lack of methodologies that facilitate the study of metastasis-to-metastasis seeding. To address this, we have developed - and describe herein - a murine surgical protocol for the selective photoconversion of lung metastases, allowing specific marking and fate tracking of tumor cells redisseminating from the lung to tertiary sites. To our knowledge, this is the only method for studying tumor cell redissemination and metastasis-to-metastasis seeding from the lungs that does not require genomic analysis.

Identifiants

pubmed: 37486129
doi: 10.3791/65732
doi:

Types de publication

Journal Article Video-Audio Media Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCRR NIH HHS
ID : S10 RR029545
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA255153
Pays : United States
Organisme : Wellcome Trust
ID : 221647/Z/20/Z
Pays : United Kingdom

Auteurs

Madeline Friedman-DeLuca (M)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.

Prachiben P Patel (PP)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.

Burcu Karadal-Ferrena (B)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.

Nicole D Barth (ND)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.

Camille L Duran (CL)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.

Xianjun Ye (X)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center.

Michael Papanicolaou (M)

Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Cell Biology, Albert Einstein College of Medicine/Montefiore Medical Center.

John S Condeelis (JS)

Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Cell Biology, Albert Einstein College of Medicine/Montefiore Medical Center; Montefiore Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center; Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center.

Maja H Oktay (MH)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center; Montefiore Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center; Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center.

Lucia Borriello (L)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Fox Chase Cancer Center; lucia.borriello@temple.edu.

David Entenberg (D)

Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center; Montefiore Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center; Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine/Montefiore Medical Center; david.entenberg@einsteinmed.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH